Susquehanna International Group, LLP Cardiovascular Systems Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$13.31 - $19.86 $2.22 Million - $3.32 Million	166,986 New	166,986 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $68,800 - $91,361	5,321 Added 32.99%	21,448 $297,000
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $71,871 - $123,982	5,312 Added 49.12%	16,127 $232,000
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $174,554 - $244,419	10,815 New	10,815 $244,000
Q4 2021 Feb 14, 2022	SELL	$18.64 - $36.77 $143,006 - $282,099	-7,672 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$32.83 - $43.0 $412,147 - $539,822	-12,554 Reduced 62.07%	7,672 $252,000
Q2 2021 Aug 11, 2021	BUY	$34.41 - $44.03 $313,406 - $401,025	9,108 Added 81.92%	20,226 $863,000
Q1 2021 May 17, 2021	BUY	$37.29 - $47.19 $559 - $707	15 Added 0.14%	11,118 $426,000
Q4 2020 Feb 16, 2021	BUY	$34.3 - $44.09 $187,037 - $240,422	5,453 Added 96.51%	11,103 $486,000
Q3 2020 Nov 16, 2020	SELL	$27.86 - $39.35 $122,946 - $173,651	-4,413 Reduced 43.85%	5,650 $222,000
Q1 2020 May 15, 2020	SELL	$30.0 - $54.18 $422,280 - $762,637	-14,076 Reduced 58.31%	10,063 $354,000
Q4 2019 Feb 14, 2020	SELL	$42.29 - $52.2 $602,167 - $743,275	-14,239 Reduced 37.1%	24,139 $1.17 Million
Q3 2019 Nov 14, 2019	BUY	$42.06 - $51.64 $759,393 - $932,360	18,055 Added 88.84%	38,378 $1.82 Million
Q2 2019 Aug 16, 2019	BUY	$33.93 - $43.66 $188,243 - $242,225	5,548 Added 37.55%	20,323 $872,000
Q4 2018 Feb 14, 2019	SELL	$25.26 - $38.43 $423,660 - $644,547	-16,772 Reduced 53.17%	14,775 $421,000
Q3 2017 Nov 14, 2017	BUY	$27.25 - $31.55 $859,655 - $995,307	31,547	31,547 $888,000

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account